Блог – PharmCAT.NET

PharmCAT.NET

Биостатистика, фармакокинетика и клинические исследования.

Домашняя страница
- О сайте
Материалы
- Быстрые команды R Project
- Ссылки
Инструменты
- Рандомизационный список
Блог
Контакты
Профиль
- Войти
- Зарегистрироваться

Найти:

Свежие записи

Частые вопросы: Регистрация и экспертиза по правилам ЕАЭС
Главные ошибки при формировании базы данных в MS Excel
Тест ClinicalTrialUtilities и ReplicateBE на Raspberry Pi 4
Julia:ReplicateBE – release 0.2.0
ClinicalTrialUtilities: обзор

Галерея

Spikevax and Moderna COVID-19 Vaccine
Source: FDA - What's New: Vaccines, Blood & Biologics RSS Feed Published on 2022-07-01 By FDA
Pulmonary-Allergy Drugs Advisory Committee Roster
Source: FDA - What's New: Drugs RSS Feed Published on 2022-07-01 By FDA
Patient Labeling Resources
Source: FDA - What's New: Drugs RSS Feed Published on 2022-07-01 By FDA
October - December 2021 | Potential Signals of Serious Risks/New Safety Information Identified by the FDA Adverse Event Reporting System (FAERS)
Source: FDA - What's New: Drugs RSS Feed Published on 2022-07-01 By FDA
Human medicines European public assessment report (EPAR): Uptravi, selexipag, Hypertension, Pulmonary, Date of authorisation: 12/05/2016, Revision: 13, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Avastin, bevacizumab, Carcinoma, Non-Small-Cell Lung;Breast Neoplasms;Ovarian Neoplasms;Colorectal Neoplasms;Carcinoma, Renal Cell, Date of authorisation: 12/01/2005, Revision: 60, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Pregabalin Sandoz, pregabalin, Anxiety Disorders;Neuralgia;Epilepsy, Date of authorisation: 19/06/2015, Revision: 13, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Executive Careers at CDER
Source: FDA - What's New: Drugs RSS Feed Published on 2022-07-01 By FDA
Human medicines European public assessment report (EPAR): Cuprymina, copper (64Cu) chloride, Radionuclide Imaging, Date of authorisation: 23/08/2012, Revision: 8, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Levetiracetam Actavis, levetiracetam, Epilepsy, Date of authorisation: 03/10/2011, Revision: 18, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Pregabalin Sandoz GmbH, pregabalin, Anxiety Disorders;Epilepsy, Date of authorisation: 19/06/2015, Revision: 12, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Zostavax, shingles (herpes zoster) vaccine (live), Herpes Zoster;Immunization, Date of authorisation: 19/05/2006, Revision: 33, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): COVID-19 Vaccine (inactivated, adjuvanted) Valneva, COVID-19 vaccine (inactivated, adjuvanted, adsorbed), COVID-19 virus infection, Date of authorisation: 24/06/2022, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Ristfor, sitagliptin,metformin hydrochloride, Diabetes Mellitus, Type 2, Date of authorisation: 15/03/2010, Revision: 25, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01
Human medicines European public assessment report (EPAR): Rydapt, midostaurin, Leukemia, Myeloid, Acute;Mastocytosis, Date of authorisation: 18/09/2017, Revision: 8, Status: Authorised
Source: EMA - Human medicines: European public assessment reports (EPARs) Published on 2022-07-01

Предыдущие записи

Тема: Scaffold от Danny Cooper.